3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
5
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Spinocerebellar Degenerations
1
Small Cell Lung Carcinoma
1
Neuroendocrine Tumors
1
Neuroectodermal Tumors, Primitive
1
Neoplasms
1
High-grade Extra Pulmonary Neuroendocrine Cancer
1
Cholangiocarcinoma
1
Bile Duct Neoplasms
1
Adenocarcinoma
1
Interventions
trifluridine tipiracil drug combination
1
spartalizumab
1
regorafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Spinocerebellar Degenerations
×
trifluridine tipiracil drug combination
×
Clear all
NCT05328908
2025-08-13
RELATIVITY-123
Bristol-Myers Squibb
Phase 3
Terminated
770 enrolled